posure control strategies. The OEB process will expand the scope of industrial
hygiene to all chemical hazards and facilitate informed decision making during
the design (and redesign) of processes,
products and facilities.
Uses of OEBs
Successful use of OEBs has been demonstrated in large manufacturing companies as well as small and medium-sized
enterprises, distributors and formulators.
OEBs are useful in product stewardship
and Responsible Care® strategies and can
be leveraged throughout the cradle-to-cradle life cycle.
Imagine the exposure risk assessment
process in a large global chemical manufacturer such as The Dow Chemical Company, which provides a single standard of
care in every facility, including smaller
external manufacturing facilities, distributors and formulators. Dow manufactures
more than 5,000 products at 188 sites in
35 countries, and uses or isolates about
70,000 chemicals to make those products.
The vast majority of these chemicals do
not have authoritative OELs, so Dow uses
occupational exposure banding to assess
risk and control worker exposures with
greater confidence. OEBs help hygienists
and engineers understand the health effects of chemicals so important decisions
about controlling worker exposure can be
made.
In Dow’s production facilities, OEBs
verify that existing engineering control
strategies are adequately protective. Since
the early 1950s, Dow hygienists have
used toxicology data to assign exposure
risk management control strategies based
on OEBs. In recent years, this process has
included use of EU risk phrases and GHS
phrases to improve the consistency of the
banding outcomes. In addition to providing information about the degree, duration and frequency of exposure, the OEBs
help prioritize and assess exposure risks
for each task and each chemical used
within each job class. Hygienists at Dow
use direct monitoring methods or surrogate exposure assessments to verify that
an existing control strategy adequately
maintains exposures below the targeted
levels in the OEB.
OEBs also help determine appropriate
chemical substitutions. In one case at
Dow, a solid material that had a moderate amount of toxicology data was
found to cause a severe rash in some
employees. The nature of these rashes
drove Dow to gather more information
and cancel the use of this material in all
Dow facilities.
Product Stewardship
Dow also uses OEBs to provide specific
end user information to groups of workers through product stewardship efforts,
particularly where an OEL may be unavailable or inadequate, or where exposure situations may result in illness. In
2005, Dow collaborated with NIOSH and
Kaiser Permanente hospitals in California
to provide updated hazard information
to endoscopy nurses for the cold disinfectant glutaraldehyde, utilizing the Dow
OEB process. Endoscopy nurses are focused on infection control and protection
against bloodborne pathogens; peak exposures to a glutaraldehyde formulation
resulted in needless respiratory sensitization of the workers.
Using this new data, Dow, NIOSH,
OSHA and Kaiser Permanente reached
out to product formulators and nurses
to warn them about the impact of peak
exposures. A strategy was developed to
communicate the Prevention through
Design approaches to control peak exposures through modifications to facility design, ventilation systems, work
practices, PPE, hazard communication
and spill cleanup. Development of the
OEB and related control approaches
and the substitution of alternatives are
believed to have contributed to a steep
reduction in illnesses related to peak
exposures.
Looking Ahead
OEBs will provide many more opportunities for industrial hygienists to
prevent occupational illness through the
application of ERAM. OEBs will help
manufacturers communicate hazards and
data-based risk management strategies.
OEBs and Prevention through Design
give chemical manufacturers, employers,
workers and end users another avenue
through which exposure risks are assessed and mitigated.
The ultimate goal is for the design
engineer to include the output of the occupational health categorization process
and exposure risk assessment into the
design of facilities, processes, equipment
and products. Designing-in appropriate
controls for all potentially hazardous
chemicals will protect workers, reduce
costs and facilitate speed-to-market.
Donna S. Heidel, MS, CIH, is a research industrial
hygienist with NIOSH in Cincinnati, Ohio. She can be
reached at (513) 533-8489 or dheidel@cdc.gov.
Susan D. Ripple, MS, CIH, is a global senior industrial hygiene manager with the Dow Chemical Company in Midland, Mich. She can be reached at (989)
636-5572 or sdripple@dow.com.
Reference
1. Leigh, J.P.: “Economic Burden of
Occupational Injury and Illness in the
United States.” Milbank Quarterly,
89: 728–772 (2011).
Environmental Analyses
Air, Water, Soil, Waste & TCLP
www.ablabs.com
10100 East Freeway, Suite 100
Houston, TX 77029
1-877-478-6060
1-713-453-6060
AIHA-LAP (Lab 101470)
NELAC (T104704213-10-2)
NVLAP (101793-0)
Accredited
Established 1988
Industrial Hygiene &
Environmental Testing
One Stop Service
Solvents
Metals
CrVl
Welding Fumes
PAH
Formaldehyde
TO-15/TO- 17
HDS
LEED
PCBs in Paint
Allergens
Microbiology
PCR
IAQ